Respiri (ASX: RSH)

Last close As at 28/10/2025

0.00 (0.00%)

Market capitalisation

Respiri is an ASX-listed company developing SaaS diagnostic solutions to support respiratory health management. Its technology detects wheeze, a typical symptom of asthma, chronic obstructive pulmonary disease and respiratory disease, to provide an objective measure of airway limitation.

Latest Insights

View More

Healthcare | Update

Respiri — Access platform-led growth prospects ahead

Healthcare | Flash note

Respiri — Early onset of synergies from Access acquisition

Healthcare | Flash note

Respiri — Raise anticipated to fund the Access acquisition

Healthcare | Flash note

Respiri — wheezo to access a larger addressable market

Happy children launch a kite in the field at sunset. Little boy and girl on summer vacation

Thematics